Australian take on International Clinical Trials Day

Media Release: Friday 20 May 2016

A clinical trial investigating reducing risk of neonatal infections related to pre-labour ruptured membranes, has been awarded the inaugural Trial of the Year Award 2016 by the Australian Clinical Trials Alliance (ACTA).

Professor Johnathan Morris, chief investigator, this morning accepted the award on behalf of the trial investigators at the Clinical Trials 2016 Breakfast and Award Ceremony this morning from Health Minister Sussan Ley.

Continue reading “Australian take on International Clinical Trials Day”

Nanoscience Facility is a $150M Investment in Australian Ingenuity

Media Release: Tuesday 3 May 2016

Recently the University of Sydney officially opened the Australian Institute for Nanoscale Science and Technology.

Nadia Levin is CEO of Research Australia, the peak group representing 160 members advocating for health and medical research in Australia. In response to requests for comment, she said:

“In 1965, Intel co-founder Gordon Moore correctly predicted exponential growth in computing technology, with computer power to double in capacity, and halve in price, every two years.

“Common computers since that time have gone from the size of houses to rooms to watches and beyond, and their capabilities today are at levels considered sci-fi even at the turn of this century.

Continue reading “Nanoscience Facility is a $150M Investment in Australian Ingenuity”

Federal Budget a Combination of Treatments, Placebos and Nocebos for Health and Medical Research

Media Release: Wednesday 4 May 2016

Research Australia, which represents 160 health and medical research organisations, has described last night’s budget as mixed bag – with some wins, some losses and some more detail required.

“The Federal Government is making all of the right noises when it comes to innovation, health and research, and it is pleasing that they remain on the agenda,” said CEO Nadia Levin.

“The budget would be described by my members as a combination of ‘treatments, placebos and nocebos’, and the challenge for government is to back it up with funding.”

Continue reading “Federal Budget a Combination of Treatments, Placebos and Nocebos for Health and Medical Research”